VirTIGO Biotechnology, Inc

We are developing novel, host-based therapeutic approaches for the treatment and prophylaxis of SARS-CoV-2, the virus that causes COVID-19.

  • Stage Product In Development
  • Industry Biotechnology
  • Location Atlanta, GA, USA
  • Currency USD
  • Founded April 2020
  • Employees 6
  • Incorporation Type C-corp
  • Website virtigobio.com

Only investors on Gust who have been granted access can view this content.

Interested in this startup? Sign In or Sign Up to request more information.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free